HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 56 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 2,426,300 | $802,000 | 0.74% |
| Cowen Prime Services LLC | 1,411,500 | $466,000 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 1,205,873 | $398,000 | 0.07% |
| Nantahala Capital Management | 5,113,958 | $1,690,000 | 0.05% |
| HighMark Wealth Management LLC | 80,000 | $26,000 | 0.02% |
| Kalos Management, Inc. | 72,858 | $24,000 | 0.01% |
| Qube Research & Technologies Ltd | 585,187 | $193,000 | 0.00% |
| WINTON GROUP Ltd | 190,146 | $63,000 | 0.00% |
| Ironwood Financial, llc | 1,571 | $1,000 | 0.00% |
| Virtu Financial LLC | 12,049 | $4,000 | 0.00% |